A randomized, open-label, phase 1 study to evaluate the effect of food on tivantinib (ARQ 197) pharmacokinetics

被引：0
|
作者：
Zahir, Hamim [1 ]
Oguma, Toshihiro [1 ]
Currie, Alexander [2 ]
Lee, Frank [3 ,4 ]
Walker, Joseph [1 ]
Tokui, Taro
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Daiichi Sankyo Europe GmbH, Munich, Germany
[3] Celerion, Neptune, NJ USA
[4] Daiichi Sankyo Pharma Dev, Tokyo, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
755
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized, crossover, phase 1 study to evaluate the effect of a strong CYP3A4 inhibitor on tivantinib (ARQ 197) pharmacokinetics in healthy subjects
    Zahir, Hamim
    Oguma, Toshihiro
    Weiss, Daniel
    Walker, Joseph
    Tokui, Taro
    CANCER RESEARCH, 2012, 72
  • [2] A phase 1, open-label, three period, randomized crossover study to evaluate the effect of food on the pharmacokinetics (PK) of lapatinib in cancer patients
    Reddy, N. J.
    Cohen, R. B.
    Whitehead, B.
    Koch, K. M.
    Stead, A.
    Beelen, A. P.
    Lewis, L. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S16 - S17
  • [3] A Phase 1, Open-Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 849 - 856
  • [4] An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics
    Mendell, J.
    Johnson, L.
    Ridout, G.
    He, L.
    Chen, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 343 - 343
  • [5] An Open-Label, Phase 1 Study to Evaluate the Effects of Hepatic Impairment on Edoxaban Pharmacokinetics and Pharmacodynamics
    Mendell, Jeanne
    Johnson, Lisa
    Chen, Shuquan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (12): : 1395 - 1405
  • [6] Evaluation of the Effect of Food and Age on the Pharmacokinetics of Oral Netupitant and Palonosetron in Healthy Subjects: A Randomized, Open-Label, Crossover Phase 1 Study
    Calcagnile, Selma
    Lanzarotti, Corinna
    Gutacker, Michaela
    Jakob-Rodamer, Verena
    Kammerer, Klaus Peter
    Timmer, Wolfgang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (05): : 377 - 386
  • [7] A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects
    Mona Darwish
    James M. Youakim
    Jim Harlick
    Daryl DeKarske
    Serge Stankovic
    Clinical Drug Investigation, 2022, 42 : 513 - 524
  • [8] A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects
    Darwish, Mona
    Youakim, James M.
    Harlick, Jim
    DeKarske, Daryl
    Stankovic, Serge
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 513 - 524
  • [9] A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults
    Rogawski, Michael A. A.
    Slatko, Gary
    EPILEPSIA, 2023, 64 (02) : 364 - 373
  • [10] Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies
    Preskorn, Sheldon
    Ereshefsky, Larry
    Chiu, Yu-Yuan
    Poola, Nagaraju
    Loebel, Antony
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (05) : 495 - 505
12345